Early Access Programs
Immunology: A Legacy of Changing Lives
Our relentless drive to discover promising new immunology pathways and targets is inspired and guided by those whose lives are touched by immune-mediated diseases. Our current successes motivate us to continue that exploration, sharpening our focus as we strive to impact their disease and their evolving expectations for a life better-lived.
AbbVie SA/NV - BE-ABBV-210008 (v1.0) - June 2021